Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Oral Antidiabetic Agents Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Oral Antidiabetic Agents Market Status and Forecast (2016-2027)
      • 1.3.2 Global Oral Antidiabetic Agents Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Oral Antidiabetic Agents Supply by Company

    • 2.1 Global Oral Antidiabetic Agents Sales Value by Company
    • 2.2 Oral Antidiabetic Agents Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Oral Antidiabetic Agents Market Status by Category

    • 3.1 Oral Antidiabetic Agents Category Introduction
      • 3.1.1 Sulfonylureas
      • 3.1.2 Meglitinides
      • 3.1.3 Biguanides
      • 3.1.4 Thiazolidinediones
      • 3.1.5 Alpha-glucosidase Inhibitors
    • 3.2 Global Oral Antidiabetic Agents Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Oral Antidiabetic Agents Market Status by End User/Segment

    • 4.1 Oral Antidiabetic Agents Segment by End User/Segment
      • 4.1.1 Home Use
      • 4.1.2 Medical Institutions
      • 4.1.3 Others
    • 4.2 Global Oral Antidiabetic Agents Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Oral Antidiabetic Agents Market Status by Region

    • 5.1 Global Oral Antidiabetic Agents Market by Region
    • 5.2 North America Oral Antidiabetic Agents Market Status
    • 5.3 Europe Oral Antidiabetic Agents Market Status
    • 5.4 Asia Pacific Oral Antidiabetic Agents Market Status
    • 5.5 Central & South America Oral Antidiabetic Agents Market Status
    • 5.6 Middle East & Africa Oral Antidiabetic Agents Market Status

    6 North America Oral Antidiabetic Agents Market Status

    • 6.1 North America Oral Antidiabetic Agents Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Oral Antidiabetic Agents Market Status

    • 7.1 Europe Oral Antidiabetic Agents Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Oral Antidiabetic Agents Market Status

    • 8.1 Asia Pacific Oral Antidiabetic Agents Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Oral Antidiabetic Agents Market Status

    • 9.1 Central & South America Oral Antidiabetic Agents Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Oral Antidiabetic Agents Market Status

    • 10.1 Middle East & Africa Oral Antidiabetic Agents Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Oral Antidiabetic Agents Market Forecast by Category and by End User/Segment

    • 12.1 Global Oral Antidiabetic Agents Sales Value Forecast (2022-2027)
    • 12.2 Global Oral Antidiabetic Agents Forecast by Category
    • 12.3 Global Oral Antidiabetic Agents Forecast by End User/Segment

    13 Global Oral Antidiabetic Agents Market Forecast by Region/Country

    • 13.1 Global Oral Antidiabetic Agents Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Wockhardt UK
      • 14.1.1 Company Information
      • 14.1.2 Oral Antidiabetic Agents Product Introduction
      • 14.1.3 Wockhardt UK Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teva
      • 14.2.1 Company Information
      • 14.2.2 Oral Antidiabetic Agents Product Introduction
      • 14.2.3 Teva Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanofi
      • 14.3.1 Company Information
      • 14.3.2 Oral Antidiabetic Agents Product Introduction
      • 14.3.3 Sanofi Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Roche
      • 14.4.1 Company Information
      • 14.4.2 Oral Antidiabetic Agents Product Introduction
      • 14.4.3 Roche Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Pfizer
      • 14.5.1 Company Information
      • 14.5.2 Oral Antidiabetic Agents Product Introduction
      • 14.5.3 Pfizer Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Novo Nordisk
      • 14.6.1 Company Information
      • 14.6.2 Oral Antidiabetic Agents Product Introduction
      • 14.6.3 Novo Nordisk Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Merck
      • 14.7.1 Company Information
      • 14.7.2 Oral Antidiabetic Agents Product Introduction
      • 14.7.3 Merck Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Eli Lilly
      • 14.8.1 Company Information
      • 14.8.2 Oral Antidiabetic Agents Product Introduction
      • 14.8.3 Eli Lilly Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Cipla
      • 14.9.1 Company Information
      • 14.9.2 Oral Antidiabetic Agents Product Introduction
      • 14.9.3 Cipla Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 AstraZeneca
      • 14.10.1 Company Information
      • 14.10.2 Oral Antidiabetic Agents Product Introduction
      • 14.10.3 AstraZeneca Oral Antidiabetic Agents Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Oral Antidiabetic Agents market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Oral Antidiabetic Agents market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Sulfonylureas
      Meglitinides
      Biguanides
      Thiazolidinediones
      Alpha-glucosidase Inhibitors

      Segmented by End User/Segment
      Home Use
      Medical Institutions
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Wockhardt UK
      Teva
      Sanofi
      Roche
      Pfizer
      Novo Nordisk
      Merck
      Eli Lilly
      Cipla
      AstraZeneca
      Buy now